Shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) have earned an average broker rating score of 1.00 (Strong Buy) from the three analysts that provide coverage for the company, Zacks Investment Research reports. Three investment analysts have rated the stock with a strong buy rating.

Brokers have set a 1-year consensus price objective of $15.33 for the company and are expecting that the company will post ($0.43) EPS for the current quarter, according to Zacks. Zacks has also given Ekso Bionics Holdings an industry rank of 91 out of 265 based on the ratings given to related companies.

A number of equities research analysts recently commented on the company. B. Riley assumed coverage on Ekso Bionics Holdings in a research report on Wednesday. They issued a “buy” rating and a $8.00 target price on the stock. Zacks Investment Research cut Ekso Bionics Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, July 13th. Finally, Rodman & Renshaw reissued a “buy” rating on shares of Ekso Bionics Holdings in a research note on Sunday, July 31st.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Shares of Ekso Bionics Holdings (NASDAQ:EKSO) traded down 0.28% during trading on Wednesday, hitting $3.61. The stock had a trading volume of 59,543 shares. The company’s market cap is $59.32 million. The stock has a 50 day moving average of $4.24 and a 200 day moving average of $5.52. Ekso Bionics Holdings has a 12 month low of $3.45 and a 12 month high of $10.08.

Ekso Bionics Holdings (NASDAQ:EKSO) last posted its earnings results on Thursday, July 28th. The company reported ($0.61) EPS for the quarter, missing analysts’ consensus estimates of ($0.28) by $0.33. Equities analysts forecast that Ekso Bionics Holdings will post ($1.74) EPS for the current fiscal year.

About Ekso Bionics Holdings

5 Day Chart for NASDAQ:EKSO

Get a free copy of the Zacks research report on Ekso Bionics Holdings (EKSO)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with's FREE daily email newsletter.